Skip to content

Novocure

US · NVCR #2889 by market cap Listed 2015
10.71 +0.02 +0.19%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Recent news

  • Rating change
    H.C. Wainwright Maintains Novocure(NVCR.US) With Buy Rating, Cuts Target Price to $46
    Market Newswire · 2026/6/18
  • Ladenburg Thalmann Maintains Novocure(NVCR.US) With Buy Rating, Raises Target Price to $31
    Market Newswire · 2026/11/10
  • Piper Sandler Maintains Novocure(NVCR.US) With Buy Rating, Maintains Target Price $29
    Market Newswire · 2026/10/26
  • Rating change
    Ladenburg Thalmann & Co. Remains a Buy on NovoCure (NVCR)
    TipRanks · 2026/2/27
  • Rating change
    J.P. Morgan Sticks to Its Hold Rating for NovoCure (NVCR)
    TipRanks · 2026/7/13
  • Rating change
    H.C. Wainwright Maintains Novocure(NVCR.US) With Buy Rating, Maintains Target Price $46
    Market Newswire · 2026/7/13
  • Evercore Maintains Novocure(NVCR.US) With Buy Rating, Maintains Target Price $20
    Market Newswire · 2026/10/30
  • Rating change
    H.C. Wainwright Maintains Novocure(NVCR.US) With Buy Rating, Raises Target Price to $52
    Market Newswire · 2026/7/24
  • Rating change
    J.P. Morgan Maintains Novocure(NVCR.US) With Hold Rating, Cuts Target Price to $17
    Market Newswire · 2026/7/13
  • Rating change
    Evercore Maintains Novocure(NVCR.US) With Buy Rating, Cuts Target Price to $16
    Market Newswire · 2026/4/6
  • Wedbush Maintains Novocure(NVCR.US) With Hold Rating, Raises Target Price to $20
    Market Newswire · 2026/7/24
  • Rating change
    H.C. Wainwright Keeps Their Buy Rating on NovoCure (NVCR)
    TipRanks · 2026/4/21
  • Rating change
    Wells Fargo Maintains Novocure(NVCR.US) With Hold Rating, Raises Target Price to $17
    Market Newswire · 2026/5/4
  • Rating change
    H.C. Wainwright Maintains Novocure(NVCR.US) With Buy Rating, Maintains Target Price $49
    Market Newswire · 2026/4/21
  • Rating change
    Piper Sandler Maintains Novocure(NVCR.US) With Buy Rating, Maintains Target Price $27
    Market Newswire · 2026/5/26
  • Rating change
    Evercore Maintains Novocure(NVCR.US) With Buy Rating, Raises Target Price to $20
    Market Newswire · 2026/5/1
  • Rating change
    H.C. Wainwright Maintains Novocure(NVCR.US) With Buy Rating, Maintains Target Price $48
    Market Newswire · 2026/5/1
  • Rating change
    H.C. Wainwright Maintains Novocure(NVCR.US) With Buy Rating, Cuts Target Price to $48
    Market Newswire · 2026/5/1
  • Wells Fargo Maintains Novocure(NVCR.US) With Hold Rating, Cuts Target Price to $15
    Market Newswire · 2026/10/30
  • Rating change
    H.C. Wainwright Maintains Novocure(NVCR.US) With Buy Rating, Maintains Target Price $52
    Market Newswire · 2026/7/24
  • Rating change
    H.C. Wainwright Maintains Novocure(NVCR.US) With Buy Rating, Raises Target Price to $49
    Market Newswire · 2026/2/27
  • Rating change
    H.C. Wainwright Maintains Novocure(NVCR.US) With Buy Rating, Raises Target Price to $47
    Market Newswire · 2026/2/12
  • Rating change
    H.C. Wainwright Maintains Novocure(NVCR.US) With Buy Rating, Maintains Target Price $39
    Market Newswire · 2026/2/6
  • Rating change
    Leerink Partners Maintains Novocure(NVCR.US) With Buy Rating, Cuts Target Price to $24
    Market Newswire · 2026/1/13

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Novocure discussion 0 comments

Add a comment